CAPRICOR THERAPEUTICS, INC. Earnings Per Share (Basic)
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Earnings Per Share (Basic) of -$0.70 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- CAPRICOR THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.70.
- CAPRICOR THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.59.
- CAPRICOR THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.62.
- CAPRICOR THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.54.
- CAPRICOR THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$2.26.
- CAPRICOR THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$1.15.
- CAPRICOR THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$0.83.
- CAPRICOR THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$1.18.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.70 10-Q · filed 2026-08-14 | -$1.29 10-Q · filed 2026-08-14 | -$1.92 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.47 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2026-03-31 | -$0.59 10-Q · filed 2026-05-13 | -$1.21 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.75 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.32 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-12-31 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1.16 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1.72 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.26 10-K · filed 2026-03-17 |
| 2025-09-30 | -$0.54 10-Q · filed 2025-11-10 | -$1.10 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.64 10-Q · filed 2025-11-10 | -$1.81 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-06-30 | -$0.57 10-Q · filed 2026-08-14 | -$1.10 10-Q · filed 2026-08-14 | -$1.27 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.66 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-03-31 | -$0.53 10-Q · filed 2026-05-13 | -$0.70 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.07 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.42 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2024-12-31 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1.15 10-K · filed 2026-03-17 |
| 2024-09-30 | -$0.38 10-Q · filed 2025-11-10 | -$0.73 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$1.04 10-Q · filed 2025-11-10 | -$1.07 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2024-06-30 | -$0.35 10-Q · filed 2025-08-11 | -$0.66 10-Q · filed 2025-08-11 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2024-03-31 | -$0.31 10-Q · filed 2025-05-14 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2023-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.83 10-K · filed 2025-03-26 |
| 2023-09-30 | -$0.25 10-Q · filed 2024-11-14 | -$0.54 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.85 10-Q · filed 2024-11-14 | -$1.15 derived: net income ÷ weighted average shares · filed 2024-11-14 |
| 2023-06-30 | -$0.29 10-Q · filed 2024-08-08 | -$0.60 10-Q · filed 2024-08-08 | -$0.91 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$1.17 derived: net income ÷ weighted average shares · filed 2024-11-14 |
| 2023-03-31 | -$0.31 10-Q · filed 2024-05-14 | -$0.61 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.88 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$1.17 derived: net income ÷ weighted average shares · filed 2024-11-14 |
| 2022-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$0.57 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$0.86 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$1.18 10-K · filed 2024-03-11 |
| 2022-09-30 | -$0.26 10-Q · filed 2023-11-14 | -$0.55 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.87 10-Q · filed 2023-11-14 | -$1.13 derived: net income ÷ weighted average shares · filed 2023-11-14 |
| 2022-06-30 | -$0.29 10-Q · filed 2023-08-08 | -$0.61 10-Q · filed 2023-08-08 | -$0.87 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$1.05 derived: net income ÷ weighted average shares · filed 2023-11-14 |
| 2022-03-31 | -$0.32 10-Q · filed 2023-05-12 | -$0.58 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.75 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.96 derived: net income ÷ weighted average shares · filed 2023-11-14 |
| 2021-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2023-03-17 | -$0.43 derived: net income ÷ weighted average shares · filed 2023-03-17 | -$0.64 derived: net income ÷ weighted average shares · filed 2023-03-17 | -$0.87 10-K · filed 2023-03-17 |
| 2021-09-30 | -$0.17 10-Q · filed 2022-11-10 | -$0.38 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.61 10-Q · filed 2022-11-10 | -$0.81 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2021-06-30 | -$0.21 10-Q · filed 2022-08-12 | -$0.44 10-Q · filed 2022-08-12 | -$0.64 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.84 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2021-03-31 | -$0.23 10-Q · filed 2022-05-11 | -$0.44 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.64 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.86 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2020-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2022-03-11 | -$0.40 derived: net income ÷ weighted average shares · filed 2022-03-11 | -$0.63 derived: net income ÷ weighted average shares · filed 2022-03-11 | -$0.88 10-K · filed 2022-03-11 |
| 2020-09-30 | -$0.20 10-Q · filed 2021-11-12 | -$0.42 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.68 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$0.23 10-Q · filed 2021-08-13 | -$0.51 10-Q · filed 2021-08-13 | ||
| 2019-12-31 | -$2.06 derived: net income ÷ weighted average shares · filed 2021-03-15 | |||
| 2018-12-31 | -$5.17 derived: net income ÷ weighted average shares · filed 2020-03-27 | |||
| 2017-12-31 | $0.10 10-K · filed 2018-03-22 | |||
| 2016-12-31 | -$1.01 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |